Poly(ethylene oxide)-modified poly(β-amino ester) nanoparticles as a pH-sensitive biodegradable system for paclitaxel delivery

Journal of Controlled Release

Volumn 86, Issue 2-3, 2003, Pages 223-234

  Potineni, Anupama ^a   Lynn, David M ^b   Langer, Robert ^b   Amiji, Mansoor M ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

^b Massachusetts Institute of Technology   (United States)

Author keywords

Nanoparticles; Paclitaxel; PEO modified; pH sensitive; Poly( amino ester); Tumor selective delivery

Indexed keywords

1,4 BUTANEDIOL DIACRYLATE; 4,4' TRIMETHYLDIPIPERIDINE; ACRYLIC ACID DERIVATIVE; ALCOHOL; ETHER; MACROGOL; NANOPARTICLE; PACLITAXEL; PIPERIDINE DERIVATIVE; PLURONIC F 108; POLOXAMER; POLY(BETA AMINO ESTER); POLYMER; RHODAMINE 123; SOLVENT; UNCLASSIFIED DRUG; WATER;

ANALYTIC METHOD; ARTICLE; BIODEGRADABILITY; CELL MEMBRANE TRANSPORT; CELLULAR DISTRIBUTION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG SELECTIVITY; DRUG SYNTHESIS; DRUG UPTAKE; ELECTRON SPECTROSCOPY FOR CHEMICAL ANALYSIS; HUMAN; HUMAN CELL; INTERNALIZATION; PH; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SURFACE CHARGE; SURFACE PROPERTY; ZETA POTENTIAL;

DRUG DELIVERY SYSTEMS; ESTERS; HYDROGEN-ION CONCENTRATION; MICROSPHERES; NANOTECHNOLOGY; PACLITAXEL; PARTICLE SIZE; POLYETHYLENE GLYCOLS;

EID: 12244283699     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(02)00374-7     Document Type: Article

References (25)

1. Jain R.K. Delivery of molecular medicine to solid tumors. Science. 271:1996;1079-1080.
2. Jain R.K. Barriers to drug delivery in solid tumors. Sci. Am. 271:1994;58-65.
3. Jain R.K. Delivery of molecular and cellular medicine in solid tumors. J. Control. Release. 53:1998;49-67.
4. Au J.L.-S., Jang S.H., Zheng J., Chen C.-T., Song S., Hu L., Wientjes M.G. Determinants of drug delivery and transport in solid tumors. J. Control. Release. 74:2001;31-46.
5. Jain R.K. Determinants of tumor blood flow: a review. Cancer Res. 48:1988;2641-2658.
6. Hobbs S.K., Monsky W.L., Yuan F., Roberts W.G., Griffith L., Torchilin V.P., Jain R.K. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc. Natl. Acad. Sci. USA. 95:1998;4607-4612.
7. Yuan F., Dellian M., Fukumura D., Leunig M., Berk D.A., Torchilin V.P., Jain R.K. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res. 55:1995;3752-3756.
8. 2 gradients in solid tumors in vivo: simultaneous high-resolution measurements reveal a lack of correlation. Nat. Med. 3:1997;177-182.
9. Dellian M., Yuan F., Trubetskoy V.S., Torchilin V.P., Jain R.K. Vascular permeability in a human tumor xenograft: molecular charge dependence. Br. J. Cancer. 82:2000;1513-1518.
10. Maeda H., Wu J., Sawa T., Matsumura Y., Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release. 65:2000;271-284.
11. Seymour L.W. Passive tumor targeting of soluble macromolecules and drug conjugates. Crit. Rev. Ther. Drug Carrier Syst. 9:1992;135-187.
12. Monsky W.L., Fukumura D., Gohongi T., Ancukiewcz M., Weich H.A., Torchilin V.P., Jain R.K. Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor. Cancer Res. 59:1999;4129-4135.
13. Nomura T., Koreeda N., Yamashita F., Takakura Y., Hashida M. Effect of particle size and charge on the disposition of lipid carriers after intratumoral injection into tissue-isolated tumors. Pharm. Res. 15:1998;128-132.
14. Brigger I., Dubernet C., Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev. 54:2002;631-651.
15. Lynn D.M., Langer R. Degradable poly(β-amino esters): synthesis, characterization, and self-assembly with plasmid DNA. J. Am. Chem. Soc. 122:2000;10761-10768.
16. Lynn D.M., Amiji M.M., Langer R. pH-responsive biodegradable polymer microspheres: rapid release of encapsulated material within the range of intracellular pH. Angew. Chem. Int. Ed. 40:2001;1707-1710.
17. Manfredi J.J., Horwitz S.B. Taxol: an antimitotic agent with a new mechanism of action. Pharmacol. Ther. 25:1984;83-125.
18. Mote P.A., Davey M.W., Davey R.A., Oliver L. Paclitaxel sensitizes multidrug resistant cells to radiation. Anticancer Drugs. 7:1996;182-188.
19. Klauber N., Parangi S., Flynn E., Hamel E., D'Amato R.J. Inhibition of angiogenesis and breast cancer in mice by microtubule inhibitors 2-methoxyestradiol and taxol. Cancer Res. 57:1997;81-86.
20. Dhanikula A.B., Panchangula R. Localized paclitaxel delivery. Int. J. Pharm. 183:1999;85-100.
21. Sherwood M.A. Data analysis in x-ray photoelectron spectroscopy. Briggs D., Seah M.P. Practical Surface Analysis. 2nd Edition:1990;555-586 Wiley, New York.
22. Crosasso P., Ceruti M., Brusa P., Arpicco S., Dosio F., Cattel L. Preparation, characterization and properties of sterically stabilized paclitaxel containing liposomes. J. Control. Release. 63:2000;19-30.
23. Nsereko S., Amiji M. Localized delivery of paclitaxel in solid tumors from biodegradable chitin microparticle formulations. Biomaterials. 23:2002;2723-2731.
24. Amiji M.M. Synthesis of anionic poly(ethylene glycol) derivative for chitosan surface modification in blood-contacting applications. Carbohydr. Polym. 32:1997;193-199.
25. J.S. Chawla, M.M. Amiji, Biodegradable poly(ε-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen, Int. J. Pharm. (in press).